Maspin is a tumor-suppressor serpin (serine protease inhibitor), which inhibits cell invasion and migration. Here, we analyzed maspin function in cell adhesion in nontransformed mammary epithelial cells and investigated the underlying mechanism involved in this process. We report that maspin acts in the early steps in the cell adhesion process. Addition of recombinant maspin rapidly increased MCF-10A cell adhesion to the endogenously deposited matrix, and conversely both an antimaspin antibody (Ab) and maspin knockdown by RNA interference resulted in decreased cell adhesion. Mutation analyses revealed that a region of 86 amino acids located between aa 139 and aa 225 was responsible for maspin effect on adhesion. In addition, we show that maspin is associated with detergent-insoluble cortical cytoskeleton elements. Collectively, these results suggest that maspin is part of the supramolecular structure of the adhesion plaque and it modulates cell adhesion via a ␤1 integrindependent mechanism.-Cella, N., Contreras, A., Latha, K., Rosen, J. M., and Zhang, M. Maspin is physically and functionally associated with ␤1 integrin regulating cell adhesion in mammary epithelial cells.
Tumor cells need to recognize and invade the surrounding extracellular matrix (ECM) in order to undergo metastatic growth in distant sites, a process intrinsically dependent on cell adhesion to the ECM. Maspin (SERPINB5) is a tumor-suppressor gene belonging to the family of serpins (serine protease inhibitors). Maspin is expressed in many tissues such as the mammary gland, prostate, skin, stomach, and uterus (1) and is down-regulated in carcinoma cells (2) . Maspin has distinct biological effects, including inhibition of tumor growth, cell migration, and invasion (3) and inhibition of angiogenesis (4, 5) . Maspin's tumorsuppressing effect appears to depend in part on its ability to increase cell adhesion to ECM (6, 7) . The molecular mechanisms underlying maspin's diverse activities are under intense investigation. While the inhibition of the pericellular urokinase-type plasminogen activator (uPA) system by maspin has been reported in prostate tumor cells (8, 9 ), biochemical analyses under several different biological contexts have not detected any inhibitory activity on several different proteases (10, 11 ). These differences may reflect different cell models and/or experimental approaches. Alternatively, it could indicate that maspin has a different mechanism of action other than protease inhibition. We have shown that transgenic animals expressing maspin in the mammary gland have smaller and fewer alveolar structures, lack functional differentiation, and could not nurse their young (12) . No increase in protease inhibitory activity was detected in the mammary gland extracts of transgenic mice, indicating that another mechanism underlies maspin's function in this system. Since the majority of the studies on maspin have been performed on tumor models that do not express maspin, the mechanism of action and cellular distribution of endogenously expressed maspin have not been investigated. In this study, we take advantage of the MCF-10A human mammary epithelial cell model, which naturally expresses high levels of maspin, to investigate its role in cell adhesion and the mechanism underlying this process.
MATERIALS AND METHODS

Antibodies and reagents
Monoclonal antibody (mAb) anti-human maspin (Pharmingen) was used for Western blot and immunofluorescence analyses on MCF-10A cells. An affinity-purified rabbit polyclonal antibody (pAb) raised against maspin reactive site loop (RSL) peptide (AbS4A) (2) and a mouse polyclonal antimaspin (whole molecule) Ab were both used in cell adhesion assays. For immunoprecipitation assay, we used a purified rabbit polyclonal anti-maspin Ab. Both mouse and rabbit antisera have been produced in our laboratory. For the studies of ␤1 integrin, the following antibodies were used: A rabbit pAb (Chemicon) was used for immunofluorescence analyses and immunoprecipitation. Purified function-blocking anti-␤1 integrin (AIIB2) (a gift from Dr. Karl S. Matlin) was used in cell adhesion assays. Anti-tubulin Ab was purchased from Sigma, Inc., and anti-human MHC I Ab (W6/32, Sigma) was a gift from Dr. Michael Z. Gilcrease. A polyclonal anti-bax was from Upstate Cell Signaling (Charlottesville, VA). The following secondary antibodies were used: Alexa Fluor® 594-conjugated goat antimouse IgG (Molecular Probes, Eugene, OR), and FITC-conjugated goat anti-rabbit (Zymed) were used for MCF-10A staining. For Western blot analyses, horseradish peroxidase (HRP)-conjugated antimouse and anti-rabbit IgGs were employed (Sigma, St. Louis, MO). Reconstituted basement membrane (Matrigel) was from BD Biosciences, and soybean trypsin inhibitor was from Roche Biochemicals.
Cell culture
MCF-10A human mammary cells (CRL-10317; American Type Culture Collection) were cultivated as monolayers in Dulbecco's modified Eagle medium (DMEM)/F12 (Invitrogen) containing 5% donor horse serum, 20 g/ml epidermal growth factor (EGF), 100 g/ml cholera toxin, 10 g/ml insulin, 500 g/ml hydrocortisone, 50 U/ml penicillin, and 50 g/ml streptomycin at 37°C and 5% CO 2 . Growth factors and hormones were purchased from Sigma. For three-dimensional (3D) cultures, cells were trypsinized, transferred to trypsin inhibitor solution, washed with serum-free medium, and embedded in Matrigel (5ϫ10 5 cells/ml). After Matrigel solidification cells were overlaid with the medium described above and allowed to grow for at least 15 d, a time required for cells to form spheroids with hollow lumens. Medium was changed every two days.
RNA interference
Sequences of small interfering RNA (siRNA) for the maspin mRNA have been previously described (13) . Selected siRNAs (229 and 455) were cloned into pSUPER.retro.puro vector (Oligo Engine) and transfected into PT67 packing cell line (Clonetech, Palo Alto, CA). Virus-containing supernatants were added to MCF-10A cells for 2 d in the presence of 2 g/ml of polybrene. A commercially available siRNA negative-control (sequence 1; Ambion) and an empty pSUPER. retro were used as controls. Two days after infection cells were selected with 1 g/ml of puromycin. Maspin down-regulation by RNAi was confirmed by Western blot analysis, quantified by Image J analysis, and cell pools stably expressing maspin siRNAs were used in adhesion assays.
Immunoprecipitation
MCF-10A cells were cross-linked with 2 mM DTSSP (3,3Ј-Dithiobis [sulfosuccinimidylpropionate]) plus 2 mM DSS (Disuccinimidyl suberate) in PBS for 30 min at room temperature. Reaction was stopped with 50 mM Tris, pH 7.4. Cell lysates were prepared in modified radio-immuno-precipitation assay (RIPA) buffer: 50 mM Tris pH 7.4, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycolate, 150 mM NaCl, 1 mM Na 3 VO 4 , 10 mM NaF, 10 mM ␤-glycerophosphate, 1 mM EDTA pH 8.0, 1 mM EGTA, 100 mM lactose, 1 mM PMSF, 5 g/ml aprotinin, and 5 g/ml leupeptin. Extracts were cleared by centrifugation and protein concentration was determined by the Bradford method. Whole cell extract (500 g) was incubated with 2 l of specific antisera or control rabbit irrelevant antiserum at 4°C for 2 h. Protein A-Sepharose-coupled beads (Amersham Pharmacia Biotech) were added and incubated for 30 min to 1 h at 4°C under constant agitation. Beads were centrifuged, washed three times with ice-cold extraction buffer containing 25 mM lactose, and boiled for 5 min in sample buffer containing 5% ␤-mercaptoethanol. Samples were split into two and loaded separately into 9 and 12% SDS-PAGE gels, respectively. Both gels were transferred to PVDF membrane (Bio-Rad) and analyzed by Western blot with anti-␤1 integrin (9% gel) and antimaspin (12% gel). Appropriate secondary antibodies were added and proteins were visualized with enhanced chemiluminescence (ECL) chemiluminescent substrate (Pierce).
Preparation of Triton X-100 soluble and insoluble fractions
Fractionation was as described (14) . Briefly, MCF-10A cells were washed twice with microtubule stabilization buffer (0.1 M pipes, pH 6.9; 2 M glycerol; 1 mM EGTA; 1 mM magnesium acetate) and extracted on ice for 5 min in buffer containing 0.2% Triton X-100, 1 mM sodium orthovanadate, 1 mM PMSF, 5 g/ml aprotinin, and 5 g/ml leupeptin. The insoluble fraction was solubilized at 4°C for 20 min in 1ϫ RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycolate supplemented with protease inhibitors). Both fractions were cleared by centrifugation, and supernatants were analyzed by Western blot as described in previous section.
Construction, expression and purification of his/glutathione S-transferase (GST)-recombinant maspin
Glutathione S-transferase (GST) and his fusion proteins (Amersham Pharmacia Biotech and BD Bioscience Clontech, respectively) were transformed in E. coli BL21 cells, expressed, and purified as instructed by the manufacturers. GST-maspin containing a Arg3 Gln point mutation (Mp*), C-terminal deletion (Mp-⌬RSL) and N-terminal deletion (Mp-⌬N) have been previously described (5), as well as fragment containing aa 1-139 (Mp-N) (13) . To generate Mp(1-225) and Mp(225-346) mutants, we introduced a BglII site in maspin cDNA by site directed mutagenesis (Stratagene kit) using the following primers: sense: 5Ј-CCTTTCCA-GAATACAGATCTGAGTATGCTCATTG-3Ј; antisense: 5Ј-CAA-TGAGCATACTCAGATCTGTATTCTGGAAAGG-3Ј, comprising nucleotides 847 to 880. This vector was digested with BglII and EcoRI, generating a fragment encoding a peptide from amino acids 225 to 346, which was subcloned to the BamH1 and EcoR1 sites of pGEX-4T1 bacteria expression vector Mp(225-346). The generation of Mp(1-225) was performed by the digestion of mutant pGEX-Mp construct with BglII and EcoRI (an additional EcoRI site is located in the vector sequence flanking the stop codon of maspin cDNA), bluntending the restriction sites and self-ligation of the blunt-ends.
Adhesion assay
For the generation of the endogenous MCF-10A-deposited matrix, we followed the method described previously (15) . MCF-10A cells were plated in 96-well dishes and allowed to reach confluence. Cells were washed with PBS and treated for 5 min with fresh sterile 20 mM NH 4 OH, and wells were extensively washed with water. Wells were blocked with 10 mg/ml of heat-denatured BSA in PBS (80°C 15 min) for 1 h at room temperature. Subconfluent cultures were trypsinized, washed with warm serum-free DMEM/F12 medium, and incubated with antibodies or recombinant proteins (0.5 M) for 30 min at 37°C (when assaying endogenous maspin enzyme-free cell dissociation solution (Cell and Mol. Technologies, Inc.) was used instead of trypsin). In all the assays, 2 ϫ 10 4 cells/well were plated in triplicates and allowed to adhere for 30 min at 37°C. When his-maspin was used, an irrelevant his-protein was used as a control. Wells were washed with warm serum free DMEM/F-12 and adhered cells were fixed with 5% gluteraldehyde and stained with crystal violet. A blank value corresponding to BSA-coated wells (Յ5% of maximal cell adhesion) was automatically subtracted. Dye was solubilized in 10% acetic acid, and absorbance was determined at 590 nM. For the function blocking study, cells were first incubated with the anti-␤1 function blocking Ab for 10 min and recombinant maspin was added for another 25 min. Alternatively, cells were incubated first with maspin for 10 min, followed by the Ab for 25 min. Adhesion was plotted as percentage of the control value. Statistical analysis was done by the Student's t test with P Ͻ 0.05 considered statistically significant or by the ANOVA analysis followed by post hoc test.
Fluorescence microscopy
For all the assays cells were plated on glass coverslips at 50 -70% density. To determine the extracellular accessibility of maspin, incubation with the first Ab was done without fixation or permeabilization on ice, to avoid its internalization (16) . To block nonspecific sites, cells were first incubated in D-MEM/F12 containing 2% BSA for 1 h at 4°C. Maspin AbS4A Ab (anti-RSL) was then added in the same medium for 2 h at 4°C. Preimmune serum was used as a negative control. Cells were then washed with ice-cold PBS, fixed with 4% paraformaldehyde, and treated with appropriate secondary antibodies for 30 min at room temperature. Cells were washed again and incubated with 10 -20 mg/ml of Hoechst 33342 for nuclei staining (Molecular Probes). To investigate maspin association with cytoskeleton, cells were first treated with cytoskeleton (CSK) buffer for 3 min (10 mM pipes, pH 6.8; 300 mM sucrose; 100 mM sucrose; 100 mM NaCl; 3 mM MgCl 2 ; 1 mM EGTA; 0.5% Triton X-100; protease inhibitors), washed twice with PBS, and fixed with 4% paraformaldehyde for 15 min at room temperature. For the other staining reactions, cells were fixed in 4% paraformaldehyde and reaction proceeded as described above. Single optical section was analyzed by a laser-scanning confocal microscope (model 510; Carl Zeiss MicroImaging, Inc.) using a Plan-Apochromat 63X/1.4 numerical aperture (NA) objective lens for Fig. 1 (17) and compares it with coefficients that are calculated if there was only random overlap (Rrand) (18) . The observed correlation (Robs) between the red and the green channel was considered significant if it was greater than 95% of the Rrand values. Pearson's correlation ranges from -1 to 1, and is equal to 1 for 100% colocalization and 0 for random overlap of proteins. The test has been applied to background-subtracted images.
RESULTS
Maspin rapidly modulates cell adhesion
MCF-10A is a nontransformed immortalized human mammary epithelial cell line, which has been extensively used as a model to explore different aspects of cell-extracellular matrix (ECM) interactions. These cells deposit endogenous ECMs and can nucleate adhesive complexes typical of epithelia (19, 20) . In addition, MCF-10A cells can recapitulate other epithelial features when grown in a 3D environment, undergoing growth arrest, forming uniform spherical colonies that 4 cells/well were seeded and cell adhesion was measured after 30 min using colorimetric reaction as described in Materials and Methods. Polyclonal anti-maspin inhibited cell adhesion by 76%, whereas no effect was detected with the anti-RSL Ab. Control, preimmune serum. Each sample was measured in triplicate. Result is representative of three independent assays. Statistical analysis was done by a t test (PϽ0.05%).
present polarized cells with a hollow lumen and basal secretion of basement membrane components (21) . These cells express high endogenous levels of maspin, providing an excellent model for investigating its function in cell adhesion. Since adhesion primary involves the interaction between the cell membrane and the substrate, we first investigated if maspin is present on the cell surface by immunofluorescence. To address this issue, cells grown on coverslips were incubated with anti-maspin without any permeabilization or fixation on ice, in order to prevent Ab internalization (see details in Material and Methods). Figure 1A showed maspin labeling along the perimeter of the cell, confirming that it is present on the external side of the plasma membrane. Given that maspin is expressed on the cell surface, we asked if incubation of cells with anti-maspin could prevent cell adhesion to its endogenously assembled matrix. To test this possibility, subconfluent MCF-10A cells were harvested with enzyme-free dissociation buffer, preincubated with polyclonal anti-maspin Ab or preimmune Ab (control) in serum-free medium, and allowed to adhere to the self-deposited matrix for 30 min. We observed a 76% decrease in cell adhesion in the presence of a polyclonal anti-maspin antiserum compared to the control serum (Fig. 1B) .
To gain further support for this finding, we employed RNA interference to specifically down-regulate maspin expression in these cells. Maspin siRNA 229 and 455 have been previously described (13) . MCF-10A cells were transfected with these siRNA-expressing vectors and selected, and maspin protein down-regulation was confirmed by Western blot analysis ( Fig. 2A, upper  panel) . Protein loading was controlled by reprobing the membrane with an anti-tubulin Ab ( Fig. 2A , lower panel). Normalization of maspin bands with that of tubulin indicated that maspin down-regulation by RNAi was ϳ82% in both 229 and 455 siRNAs cells (Fig. 2B ). siRNA-expressing cells exhibited significantly less adhesion compared with the control cells (Fig. 2C) , further supporting maspin's role in adhesion. Previously, Seftor et al. observed an increase in integrin gene expression after 18 -24 h of incubation with recombinant maspin (22) , suggesting that maspin acts indirectly in the adhesion process. In our experiments, however, maspin effect was observed within 30 min. To re-ensure that, in our model, maspin acts in a different kinetics, we applied a similar approach, incubating MCF-10A cells with recombinant GST-maspin for a short period of time. For this purpose cells were trypsinized, which renders the endogenous maspin inactive (10, 23, 24) . After harvesting, cells were washed and preincubated either with GST or increasing concentrations of GST-maspin and adhesion assay was carried out as described in Material and Methods. We observed a dose-dependent increase in cell adhesion, which was up to 3-fold higher than control cells incubated with GST alone (Fig. 2D) . We conclude that exogenously added recombinant maspin can rapidly increase MCF-10A cell adhesion to its endogenous matrix. Altogether, these results indicate that in the MCF-10A model maspin interferes with early steps in the adhesion process and therefore appears to act differently from previous studies done in tumor and stromal cells. 4 cells/well were plated on endogenous matrix, and cell adhesion was quantified as described in Materials and Methods. We observed a dose-dependent increase in cell adhesion in the presence of maspin. This result is representative of three independent assays. Statistical analysis was done by a t test (PϽ0.05%).
Maspin promotes cell adhesion independently of its RSL domain
The RSL is a conserved serpin domain, which is essential for its antiprotease activity (25) . The maspin RSL domain possesses unique sequence and structure, which makes it unlikely to be involved in protease inhibition (11) . However, it has been shown to be essential for maspin-mediated inhibition of cell invasion and migration (7, 23) . To test whether maspin RSL domain is also involved in its rapid action on cell adhesion in normal mammary epithelial cells, MCF-10A cells were incubated with a purified pAb raised against the RSL domain (AbS4A) of maspin (2) and allowed to adhere to its endogenous matrix as described above. Surprisingly, the treatment with anti-RSL Ab had no detectable effect on MCF-10A adhesion to the selfdeposited matrix (Fig. 1B) . This lack of effect was not due to inaccessibility of the maspin RSL domain, since this Ab could detect maspin on the cell surface by immunofluorescence (Fig. 1A) . To confirm this observation we used two independent approaches: 1) we compared the effect of wild-type (WT) recombinant maspin with that of mutant proteins bearing a point mutation in the RSL loop (Mp*) and a C-terminal deletion of the RSL domain (Mp-⌬RSL) ( Fig. 3; and 2 ) WT maspin was preincubated with an anti-RSL Ab before incubation with cells (23, 26) . Under both conditions, the ability of maspin to increase cell adhesion was assayed as described above. We observed that recombinant maspin carrying either a C-terminal deletion or point mutation in the RSL resulted in an increased adhesion, comparable to WT maspin (Fig.  3B ). In addition, no difference in cell adhesion could be detected when maspin was preincubated with an anti-RSL Ab (Fig. 3C) .
We next attempted to determine which portion of maspin is important for this rapid induction of adhesion. For this purpose we generated several maspin constructs for the production of mutant maspin proteins as described in Materials and Methods. Initially, we used proteins containing only the first 139 aminoacids (Mp-N) and another fragment where this Nterminal portion had been deleted (Mp-⌬N) (5) (Fig.  4) . We observed that Mp-N failed to increase cell adhesion, while the carboxyl half of the molecule retained most of the effect observed with WT maspin (Fig. 4B) . To further identify the functional domain, we constructed two additional mutants, which contain amino acids 1-225 and amino acids 225-346, respectively (Fig. 4A) , and tested these proteins in cell adhesion assays. Mp(225-346) had no effect on MCF-10A adhesion to the endogenous matrix (Fig. 4C) . Mp(1-225), in contrast, retained a decreased, but significant ability to sustain cell adhesion (Fig. 4C ). All together, these experiments indicate that maspin RSL domain is not involved in maspin-dependent increase in cell adhesion. However, a portion of the 86 residues between amino acid 139 -225 appears to contain the domain responsible for the rapid effect of maspin on MCF-10A adhesion to the self-deposited matrix. These findings further support the idea that maspin acts via a different mechanism in the MCF-10A model.
Maspin can override the inhibiting effect of anti-␤1 integrin
Cells interact with the ECM proteins via transmembrane proteins, of which the integrin superfamily of cell surface receptors has been the most studied. MCF-10A matrix is mainly composed of laminin-5 (19) , to which these cells adhere predominantly via ␣3␤1 integrin (27, 28) . Therefore, in order to investigate the involvement of ␤1 integrin in maspin-induced increase in adhesion, we examined the effect of maspin in adhesion in 4 cells/well were plated on endogenous matrix and adhesion was quantified as described in Materials and Methods. C) Antibodies were preincubated with GST-maspin at the indicated dilutions for 30 min and sequentially incubated with cells for additional 30 min. Adhesion assays were performed as described. We observed a 2-to 3-fold increase in cell adhesion in the presence of maspin, which did not change significantly when cells were incubated with mutants of the RSL region or with anti-RSL Ab. Result represents three independent assays. Statistical analysis was done by ANOVA (PϽ0.05%).
conditions where this integrin subunit was occupied by the function-blocking Ab AIIB2 (Fig. 5) . As shown in previous results, cells exhibited a 5-fold increase in cell adhesion in the presence of maspin (Fig. 5, bar number  3) . Surprisingly, cells that were preincubated with AIIB2 followed by incubation with his-maspin still exhibited 5-fold increase in adhesion (Fig. 5 , compare bar number 5 with inset), albeit 50% less cells adhered (compare bars 3 and 5). Since adhesion of MCF-10A cells to its self-deposited matrix is mediated by ␤1 integrin, the concentration of AIIB2 used (1 g/ml) was probably not enough to completely block all the ␤1 integrin sites, since we observed only a 50% adhesion inhibition with this concentration (inset). Therefore, the unblocked ␤1 integrin sites most likely account for the same fold increase in adhesion in the presence of maspin. No effect was observed when an anti-human MHC I Ab was used (bar number 4), indicating that this effect was specific for ␤1 integrin. Interestingly, when maspin was added before the anti-␤1 integrin, the inhibiting effect given by this integrin Ab was no longer observed (Fig. 5, bar number 6 ). This result indicates that even though the total adhesion is inhibited, preincubation of cells with maspin could override the inhibition.
Maspin colocalizes and is physically associated with ␤1 integrin
Given that maspin effect appears to be membraneassociated and can interfere with the adhesion inhibition given by anti-␤1 integrin, we postulated that maspin could also be physically associated with this integrin subunit. We tested this hypothesis by coimmunoprecipitation using antimaspin and anti-␤1 integrin antibodies. MCF-10A cells were chemically cross-linked, lysed in RIPA buffer, and immunoprecipitated with antimaspin or anti-␤1 integrin antibodies under stringent conditions to disrupt the noncovalent association between the integrin and maspin. An irrelevant rabbit antiserum was used as a negative control (Fig. 6A) . Following immunoprecipitation, protein complexes were dissociated under reducing condition to break covalent cross-linked bonds. Western blot analysis of the precipitated material revealed that cell lysates contained substantial amounts of maspin (Fig. 6A , left lower panel, lane 2) and ␤1 integrin (Fig. 6A, right upper panel,  lane 5 ). In addition, we observed that ␤1 integrin was detected in the maspin immunoprecipitate (Fig. 6 , left upper panel, lane 2). Conversely, maspin was also detected in the ␤1 integrin immunoprecipitate (Fig. 6A,   Figure 5 . Maspin can override the inhibiting effect of anti-␤1 integrin. MCF-10A cells were harvested and preincubated with indicated recombinant proteins. Anti-MHC I (4) or anti-␤1 integrin (5) were incubated with cells for 10 min (1 g/ml), and recombinant his-maspin was added subsequently (0.5 M) for another 25 min. In bar number 6, his-maspin was added to cells first (10 min), and anti-␤1 integrin was added subsequently. Adhesion was measured as described previously. This result is representative of four independent experiments. Inset: anti-␤1 integrin down-regulates MCF-10A adhesion by itself. Statistical analysis was done by ANOVA (PϽ0.05%). (Fig. 1A) , there is a possibility that maspin may associate with ␤1 integrin in the intracellular or intramembrane space. For this reason, we chose to perform chemical cross-linking with DTSSP and DSS simultaneously, two cross-linking reagents that are membrane-impermeable and -permeable, respectively. DTSSP would cross-link maspin and ␤1 integrin if their interaction occurs extracellularly. DSS would cross-link them if their interaction occurs in the intramembrane or intracellular space. With this approach we assured ourselves that maspin and ␤1 integrin interaction would be cross-linked and detected. Notably, under reducing conditions maspin and ␤1 integrin migrated at their respective MW. No high MW complex was observed in Western blot analysis (data not shown), indicating that they were preferentially cross-linked by DTSSP, which can be cleaved by reducing agents, and not by DSS, which cannot be reduced and therefore can't be cleaved. Since DTSSP cannot cross the plasma membrane, and thus it can only cause cross-linking among cell surface proteins, these data together suggest that maspin associates with ␤1 integrin extracellularly.
Since maspin interacts with ␤1 integrin, we reasoned that these proteins would also localize in the same place in MCF-10A cells. To determine if there was colocalization, we carried out indirect double-immunofluorescence to analyze the staining patterns of maspin and ␤1 integrin by confocal microscopy (Fig. 6B) . Cells were first cultivated as monolayers on coverslips, fixed, permeabilized, and stained with a mAb anti-maspin (Fig.  6B, a) and a polyclonal anti-␤1 integrin (Fig. 6B, b) . Strong staining along the cell perimeter was detected for both maspin and ␤1 integrin (Fig. 6B, a and b,  arrows) . Importantly, visual inspection of the merged image showed some sites of their colocalization on the membrane (Fig. 6B, d, arrows) , which was quantitatively confirmed by the Pearson's correlation coefficient (17) .
Epithelial cells grown in monolayers can display several of their normal functions. They can proliferate, migrate, differentiate, and die. However, under these conditions they cannot recapitulate the epithelial architecture, which depends on the hallmark properties of epithelial cells, i.e., their ability to polarize, forming apical and basolateral surfaces with vectorial deposition of ECM elements. Since ␤1 integrin expression is altered in cells plated on plastic and proper signal transduction depends on the spatial organization of the cell (29, 30), we were interested in confirming whether maspin and ␤1 integrin colocalize in polarized epithelial cells in 3D structure compared to that which were cultivated in monolayers. To verify the colocalization of maspin and ␤1 integrin in 3D culture, we analyzed maspin and ␤1 expression and distribution in MCF-10A acini. MCF-10A cells were seeded in the Matrigel and allowed to develop an acinar-like structure for 15 d. Acinar structures were analyzed on frozen section by confocal microscopy. MCF-10A cells organized to form a single polarized layer surrounding a hollow lumen (Fig. 6C) . Analysis by immunofluorescence revealed maspin localized predominantly to the basal membrane (Fig. 6C, a, arrow) and, to a lesser extent, to sites of cell-cell contact (Fig. 6C, a, arrowhead) . This finding contrasts with maspin staining done on monolayer cultures, where no maspin was observed on sites of cell junctions. It is possible that in nonpermeabilized cells the access of the Ab to cell junction sites is limited. Alternatively, maspin localization in cell-junction depends on proper cell polarization, which is not achieved in monolayer cultures. ␤1 integrin appeared to be equally distributed between cell-matrix and cellcell contacts (Fig. 6C, b, arrow and arrowhead, respectively) . The merged image indicated that maspin and ␤1 integrin colocalize in some sites in polarized MCF-10A acini as well (Fig. 6C, d, arrows) , which was further confirmed by quantitative analysis. All together, these data indicate that maspin increases cell adhesion via a ␤1 integrin-dependent mechanism.
Maspin is associated with the Triton X-100 insoluble cytoskeleton fraction
Binding of integrin receptors to extracellular ligands is a complex process involving receptor-ligand interactions at the cell-substrate interface and assembly of cytoskeletal and adhesion plaque proteins (31) . The rapid cellular response to recombinant maspin indicates that maspin acts on the initial steps of cellsubstrate interaction and could be connected to the underlying cytoskeleton framework. To address this question, we first determined maspin's solubility in a nonionic detergent. Accordingly, MCF-10A cells were first extracted with Triton X-100 buffer (Triton-soluble fraction) and sequentially extracted with RIPA buffer (Triton-insoluble fraction). Western blot analysis confirmed that maspin was present in both fractions (Fig.  7A, upper panel) . Purity of fractions was confirmed by reprobing the membrane with an anti-bax Ab, a Tritonsoluble cytosolic protein (Fig. 7A, lower panel) . To localize the cytoskeleton-associated maspin in the cell immunostaining was performed on cells that had been treated for 3 min with CSK buffer before fixation (see Material and Methods for details). In agreement with the cellular fractionation, maspin staining was resistant to Triton extraction and was found at the periphery of the cell (Fig. 7B, a) . Notably, ␤1 integrin staining had a very similar distribution (Fig. 7B, b) . Quantitative analysis indicated some degree of colocalization, although it is difficult to visually determine sites of colocalization (Fig. 7B, d) . These results suggest that maspin is connected to the cortical membrane cytoskeleton and may be part of the supramolecular structure of the adhesion plaque.
DISCUSSION
This study was designed to uncover the mechanisms underlying a maspin-induced increase in cell adhesion. We have provided strong evidence that maspin acts rapidly on the cell surface, stimulating cell adhesion via integrin receptors. Maspin is physically and functionally associated with ␤1 integrin. In particular, maspin and ␤1 integrin are colocalized on the cell surface, and maspin is also found to be associated with cytoskeleton elements, suggesting that it is part of the supramolecular structure of adhesion plaques. 
Maspin increases cell adhesion independently of its RSL domain
In contrast to most published results, we have used nontransformed mammary epithelial cells (MCF-10A) that express high endogenous concentration of maspin. In our adhesion assays we found that maspin increased cell adhesion independently of its RSL domain. This result is in apparent contrast with previous reports, which showed that maspin's effect on tumor and stromal cells was dependent on its RSL domain (7, 23, 32) . While this difference may be due to the use of different cellular models, it may also indicate that maspin acts differently in normal vs. tumor or stromal cells. In MDA-MD-231 breast tumor cells, maspin appears to increase cell adhesion via a mechanism, which leads to increased ␣5␤1 integrin mRNA expression (22) . However, in these studies cells were treated with maspin for 18 to 24 h, suggesting that maspin acted indirectly in the cell adhesion process. The fact that we observed maspin acting rapidly and independently of the RSL domain indicates that maspin is acting via a different mechanism in the MCF-10A model to regulate cell adhesion. Similarly, maspin inhibition of angiogenesis is also independent of the RSL domain (4, 5) . In addition, a third distinct domain in maspin appears to mediate maspin interaction with type I and III collagen (33) . All together these data suggest that maspin is a multifunctional protein that can exert its effects via different molecular mechanisms. We have found that a region spanning amino acids 139 -225 is responsible for the maspin's positive effect on adhesion. Based on the X-ray crystal structure of maspin (24, 34) , this region contains several structural motifs including s3A, s3C, and s1B. For strand s3A, due to its structure, many of the side chains are buried inside the protein. However, strands s3C and s1B (aa 180 -210) are surface-exposed. It is likely that amino acids in strands s3C and s1B may mediate cell-adhesion effect. There is also a possibility that a deletion of this region may affect the folding and structure of other regions of maspin. Thus, we plan to perform "domain-swapping" experiment using different serpins and site-specific mutagenesis to identify the specific amino acids that are functionally important for adhesion.
Maspin can overcome the inhibiting effect of anti-␤1 integrin
We observed an overall decrease in cell adhesion when cells are first incubated with anti-␤1 integrin. Interestingly, this effect was abrogated when cells were incubated with maspin before the Ab addition. Although we cannot completely explain this observation yet, we envision at least four possible interpretations. 1) When added before maspin, anti-␤1 integrin could act as a dominant-negative effector in the adhesion process, since it inhibits adhesion by itself; 2) anti-␤1 integrin could be interfering in the maspin binding per se, perhaps competing for the same site. AIIB2 binds to a small region on the ␤1 integrin subunit (residues 207-218), which is the same region where activating anti-␤1 integrin mAb binds (35) . In this model maspin could be acting like an activating anti-␤1 integrin; 3) maspin could polymerize and form a lattice around the adhesion site, which would prevent AIIB2 from binding to its epitope. In fact maspin has been shown to form polymers in vitro (10, 24, 36) and in vivo (Latha et al., unpublished data); 4) maspin interaction to its ligand on the cell surface could result in a conformational change of the ␤1 integrin, which would hide or mask AIIB2 binding site. Finally, these possibilities are not mutually exclusive, so it remains possible that two or more of these events might be taking place.
Maspin is linked to the cytoskeleton and is physically associated with ␤1 integrin
We have demonstrated here that maspin associates with ␤1 integrin in MCF-10A cells by reciprocal coimmunoprecipitation and colocalization under confocal microscope. Since they were cross-linked by the membrane impermeable agent DTSSP, it is possible that the extracellular portions of ␤1 integrin and maspin are close enough to be involved in a direct interaction. However, an indirect interaction between maspin and ␤1 integrin, via a third molecule, is equally possible.
Maspin biological effects have been previously assigned to the cell surface environment (1, 7, 26) . That maspin associates with ␤1 integrin and that it is detected on the cell surface further support this hypothesis. However, in our adhesion assays, maspin has been incubated with cells at 37°C, and therefore it remains possible that maspin was internalized and acted in the intracellular compartment. We observed that maspin stained to the cortical membrane cytoskeleton and was detected in the Triton-insoluble fraction. Since extracellular molecules, which interact with true membrane proteins, remain bound to skeleton framework on nonionic detergent extraction, it is possible that the Triton-resistant maspin is located outside the cell (37) (38) (39) . Maspin appears to be a peripheral rather than an integral membrane protein (1) . The observation that a fraction of cellular maspin is Triton-resistant argues that maspin at times can behave like a fibrous or structural protein. Interestingly, cytoskeleton proteins acquire Triton insolubility very early or concomitantly to the process of adhesion (39) . Therefore, we postulate that maspin can modulate cell adhesion as being part of the supramolecular adhesion structures.
The ECM has been proven vital to mammary gland development, and differentiation (40) . Particularly, ␤1 integrin signaling is essential for optimal prolactininduced milk protein gene expression (41) , mammary cell proliferation (42) , and cell survival (43) . In addition, ␤1 integrin is critical for initiation and maintenance of mammary tumor growth (44) , and functionblocking anti-␤1 integrin was able to reverse the malignant phenotype (45) . In accordance with ␤1 integrin studies, targeted maspin expression in the mammary gland disrupted lobular-alveolar structure and milk protein production (12) and, in tumor models, maspin can block tumor growth and invasion (3), processes that depend on cell-extracellular matrix interaction. Besides, maspin and ␤1-deficient mice displayed remarkably similar phenotypes, further supporting their functional link in vivo (46, 47) . All together, these data suggest that maspin and ␤1 integrin may be part of a common signaling machinery, which plays a crucial role in mammary gland function and in tumor initiation and progression. 
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SPECIFIC AIMS
The purposes of our study are to investigate the role of maspin in cell adhesion and to identify the molecular domain involved in this process and the underlying mechanism.
PRINCIPAL FINDINGS
Maspin rapidly modulates cell adhesion
In a different approach from most previous studies, we have used a nontransformed mammary epithelial cell line (MCF-10A cells), which expresses high concentration of maspin. Since adhesion primary involves the interaction between the cell membrane and the substrate, we first investigated whether maspin was present on the cell surface by immunofluorescence. Using nonpermeabilized cells to prevent internalization of the antibody (Ab), we observed maspin staining at the periphery of the cell and confirmed its expression on the external side of the membrane. We next analyzed a possible role of endogenous maspin in cell adhesion as well as exogenous addition of recombinant maspin by cell adhesion assays. We found that incubation of cells with antimaspin or maspin down-regulation by RNAi decreased cell adhesion. Accordingly, incubation of cells with recombinant maspin increased cell adhesion. These effects were observed within 30 min, suggesting that maspin acts in the early steps of the cell adhesion process.
Mutation analyses reveal a new domain involved in maspin effect on cell adhesion
Previous studies done in tumor cell models indicate that the maspin RSL domain (reactive site loop) is essential for its positive effect on adhesion. To determine the domain of maspin, we tested the effect of various maspin mutants on cell adhesion. Differently from the studies in mammary tumors, we found that a domain comprising amino acid 139 to 225, and not the RSL domain, retained a positive effect on cell adhesion.
Maspin is physically associated with ␤1 integrin
Cell adhesion to extracellular matrix is mediated by integrins to a great deal. In our model system, we used the endogenous matrix deposited by MCF-10A cells, which contains predominantly laminin-5. Therefore, we hypothesized that maspin could be modulating cell adhesion via a ␤1 integrin, a major laminin-5 receptor in this cell line. Using total protein extracts, we observed that ␤1 integrin coimmunoprecipitated with maspin. Reciprocally, maspin was also coimmunoprecipitated with ␤1 integrin. MCF-10A adhesion to its endogenous matrix could be inhibited 50% with a function-blocking anti-␤1 integrin. Interestingly, this effect was abrogated when cells were incubated with maspin before addition of the Ab, indicating that maspin could override the inhibition given by the anti-␤1 integrin.
Maspin colocalizes with ␤1 integrin
To further confirm and extend our findings, we performed indirect double-immunofluorescence to analyze the staining pattern of maspin and ␤1 integrin by confocal microscopy. We observed a significant colocalization of these two molecules, predominantly at the cell membrane site, which was further confirmed by quantitative analysis. Since both integrin expression and signaling are altered in cells grown on flat surfaces, we intend to confirm this result in cells cultivated in matrigel, in which cells can develop into three-dimensional acinar structures which recapitulate typical features of the epithelial architecture. Similarly to cells grown on flat surfaces, maspin and ␤1 integrin also colocalized in three-dimensional culture, which was observed for both basement membrane and cell-cell contact sites.
Maspin is associated with the Triton X-100 insoluble cytoskeleton fraction
Binding of integrin receptors to extracellular ligands involves receptor-ligand interactions at the cell-substrate interface and assembly of cytoskeletal and adhesion plaque proteins. The rapid cellular response to recombinant maspin indicates that maspin acts on the initial steps of cell-substrate interaction and could be connected to the underlying cytoskeleton framework. To test this possibility, we determined maspin's solubility in Triton X-100, a nonionic detergent. Maspin was detected in the soluble as well as in the insoluble Triton X-100, indicating that a fraction of it is associated with the cytoskeleton. In addition, immunofluorescence analysis revealed that the insoluble maspin fraction is present at the periphery of the cell, indicating that maspin is connected to the cortical membrane cytoskeleton and may be part of the supramolecular structure of the adhesion plaque.
CONCLUSIONS AND SIGNIFICANCE
Our study forms the following conclusions: 1) maspin acts rapidly to increase cell adhesion, indicating that it takes part of the early steps of the cell adhesion process; 2) differently from what was observed in tumor and stromal models, we have found that maspin effect on adhesion does not involve the RSL domain; 3) maspin is physically associated with ␤1 integrin, suggesting that it may modulate its ability to mediate cell adhesion. In agreement with that, these molecules colocalize on the cell membrane site; 4) a fraction of maspin is associated with the Triton X-100-insoluble fraction, suggesting that it is part of the supramolecular structure of adhesion plaques.
In our nontransformed cell model, we find that maspin acts rapidly and independently of the RSL domain. This is in apparent contrast with studies done with stromal and tumor cells, where maspin-induced increase in cell adhesion depended on RSL, and the effect was observed after 18 -24 h of incubation with recombinant maspin. In addition, one previous study observed an increase in integrin mRNA expression following a long-term treatment of maspin, whereas in our model we found that maspin and ␤1 integrin were physically linked. While this difference may be due to the use of different cellular models, it may also indicate that maspin influence ␤1 via two different manners: directly, modulating ␤1 integrin function in the cell membrane microenvironment, and indirectly, up-regulating its expression. Alternatively, maspin could act differently in normal vs. tumor or stromal cells. These are interesting hypotheses that remain to be tested. Finally, it is interesting to observe that, in addition to the new domain described here, two distinct domains are responsible for the effect of maspin on angiogenesis and interaction with collagens, respectively, suggesting that maspin exerts its effects via different molecular mechanisms.
Our cell fractionation analysis indicates that maspin is present in a soluble fraction as well as in a detergent-insoluble cytoskeleton fraction, suggesting that maspin may be part of the adhesion plaque. Whether the maspin-insoluble fraction is intracellular or the extracellular maspin pool is linked to the cytoskeleton via its interaction with ␤1 integrin remains to be investigated.
␤1 integrin has been proven vital for several mammary epithelial cell functions, including growth, differentiation, apoptosis, and cancer progression. In agreement with these observations, targeted maspin Figure 1 . Polyclonal antimaspin Ab, but not an anti-RSL Ab generated against the RSL domain of maspin, inhibits MCF-10A cell adhesion to the self-deposited matrix. A) MCF-10A cells were plated on coverslips and stained with the rabbit anti-RSL (AbS4A) Ab on ice, to prevent the internalization of the Ab. Preimmune serum revealed no staining (data not shown). This imagine is representative of two independent assays. Confocal microscope analysis revealed maspin on the cell surface. Bar, 20 m. B) MCF-10A cells were harvested with enzyme-free dissociation buffer, and preincubated with the indicated antibodies. 2 ϫ 10 4 cells/well were seeded and cell adhesion was measured after 30 min using colorimetric reaction. Polyclonal anti-maspin inhibited cell adhesion by 76%, whereas no effect was detected with the anti-RSL Ab. Control, preimmune serum. Each sample was measured in triplicate. Result is representative of 3 independent assays. Statistical analysis was done by a t test (PϽ0.05%). expression in the mammary gland resulted in disrupted lobular-alveolar structure, and in tumor models maspin can block tumor growth and invasion.
In conclusion, our study provided evidence that maspin and ␤1 integrin may be part of a common signaling machinery, which plays a crucial role in mammary gland function and in tumor initiation and progression. 
